Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
09th week of 2021 patent applcation highlights part 10
Patent application number
Title
Published
20210059996
SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION
2021-03-04
20210059997
PROPHYLACTIC AGENT AND/OR THERAPEUTIC AGENT FOR CATARACT, MEDICINAL COMPOSITION FOR PREVENTING AND/OR TREATING CATARACT, USE OF PPAR ACTIVATOR FOR PRODUCING SAME, AND EYEDROPS
2021-03-04
20210059998
OPHTHALMIC COMPOSITION
2021-03-04
20210059999
COMBINATION TREATMENT OF SARCOGLYCANOPATHIES
2021-03-04
20210060000
NOVEL NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF
2021-03-04
20210060001
THERAPEUTIC TARGETING OF THE BAP1 COMPLEX IN CANCER
2021-03-04
20210060002
METHODS OF PREVENTING OR TREATING FLAVIVIRUS VIRUS INFECTIONS AND METHODS OF INHIBITING THE ENTRY OF FLVIVIRUS, ENTEROVIRUS OR LENTIVIRUS INTO HOST CELLS
2021-03-04
20210060003
TREATMENT OF CANCER
2021-03-04
20210060004
BUPROPION AS A MODULATOR OF DRUG ACTIVITY
2021-03-04
20210060005
BUPROPION AS A MODULATOR OF DRUG ACTIVITY
2021-03-04
20210060006
COMPOSITIONS AND METHODS FOR TREATING GLIOBLASTOMA BY MODULATING A MGMT ENHANCER
2021-03-04
20210060007
ANTI-INFLAMMATORY COMPOSITION
2021-03-04
20210060008
METHODS OF TREATING BREAST CANCER WITH TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS
2021-03-04
20210060009
NOVEL METHODS
2021-03-04
20210060010
ORGANIC COMPOUNDS
2021-03-04
20210060011
CRYSTALLINE MONOMESYLATE SALT OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZ- O[1,2-a]PYRAZIN-8-AMINE
2021-03-04
20210060012
METHODS AND COMPOSITIONS FOR TREATING MOVEMENT DISORDERS
2021-03-04
20210060013
Method for Preventing Triple Negative Breast Cancer in Predisposed Subjects
2021-03-04
20210060014
COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS
2021-03-04
20210060015
THERAPEUTIC DRUG FOR DYSKINESIA
2021-03-04
20210060016
ANTICANCER AGENT
2021-03-04
20210060017
METHOTREXATE OPHTHALMIC SOLUTION
2021-03-04
20210060018
TOPICAL ADMINISTRATION OF MEK INHIBITING AGENTS FOR THE TREATMENT OF SKIN DISORDERS
2021-03-04
20210060019
PHARMACEUTICAL COMPOSITIONS COMPRISING IBRUTINIB
2021-03-04
20210060020
PHARMACEUTICAL FORMULATIONS
2021-03-04
20210060021
Method of Adjuvant Cancer Treatment
2021-03-04
20210060022
TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
2021-03-04
20210060023
Cycloalkyl-Diamines for the Treatment of Inflammation
2021-03-04
20210060024
GENERATION OF MUSCLE LINEAGE CELLS AND THERAPEUTIC USES THEREOF
2021-03-04
20210060025
COMBINATION THERAPY FOR TREATING CANCER
2021-03-04
20210060026
COMBINATION THERAPIES FOR INHIBITION OF POLO-LIKE KINASE 4
2021-03-04
20210060027
SUBSTITUTED BENZENE COMPOUNDS
2021-03-04
20210060028
DNA-PK INHIBITORS
2021-03-04
20210060029
Use of Minaprine to Reduce Tumor Growth
2021-03-04
20210060030
METHOD FOR TREATING CANCER
2021-03-04
20210060031
USE OF PHOSPHOINOSITIDE 3-KINASE INHIBITORS FOR TREATMENT OF VASCULAR MALFORMATIONS
2021-03-04
20210060033
ORALLY ADMINISTERED COMBINATIONS OF BETA-LACTAM ANTIBIOTICS AND AVIBACTAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONS
2021-03-04
20210060034
The Pharmaceutical Composition Intended to Inhibit HIV Infectivity in Order to Treat the Acquired Immune Deficiency Syndrome (AIDS) and Its Complications
2021-03-04
20210060035
APPLICATION OF COMPOUND IN PREPARATION OF DRUG FOR TREATMENT OF HAEMORRHAGIC STROKE
2021-03-04
20210060036
LIQUID POLYMER DELIVERY SYSTEM FOR EXTENDED ADMINISTRATION OF DRUGS
2021-03-04
20210060037
Methods For Producing Chemoembolic Agents For The Delivery Of Anti-Cancer Agents
2021-03-04
20210060038
COMPOSITIONS FOR ELIMINATING BACTERIAL PROMOTORS OF COLORECTAL CANCER BY INTRALUMINAL APPLICATION
2021-03-04
20210060039
COMBINATION OF BCL-2/BCL-XL INHIBITORS AND CHEMOTHERAPEUTIC AGENT AND USE THEREOF
2021-03-04
20210060040
CANNABINOID RECEPTOR MODULATORS
2021-03-04
20210060041
STING AGONISTS FOR TREATING BLADDER CANCER AND SOLID TUMORS
2021-03-04
20210060042
Patentiflorin A Analogs as Antiviral Agents
2021-03-04
20210060043
METHODS OF TREATING HEART FAILURE WITH REDUCED EJECTION FRACTION
2021-03-04
20210060044
METHODS FOR TREATING BLADDER CANCER BY ACTIVATION OF HEDGEHOG SIGNALING USING A METHYLATION INHIBITOR
2021-03-04
20210060045
PHARMACEUTICAL PASTE FORMULATIONS FOR SITE SPECIFIC APPLICATION
2021-03-04
20210060046
USE OF VERBASCOSIDE IN PREPARATION OF DRUG FOR PREVENTING OR TREATING GLOMERULAR PODOCYTE INJURED RENAL DISEASE
2021-03-04
20210060047
COMPOSITION OF N-PALMITOYL-ETHANOLAMIDE AND RUTIN IN CO-MICRONIZED FORM
2021-03-04
20210060048
COMPOSITIONS FOR IMPROVING JOINT HEALTH
2021-03-04
20210060049
PHYTOCHEMICAL-ANTIBIOTIC COMBINATION FOR THE TREATMENT OF A BACTERIAL INFECTION
2021-03-04
20210060050
N4-Hydroxycytidine and Derivatives and Anti-Viral Uses Related Thereto
2021-03-04
20210060051
COMBINED MODALITIES FOR NUCLEOSIDES AND/OR NADPH OXIDASE (NOX) INHIBITORS AS MYELOID-SPECIFIC ANTIVIRAL AGENTS
2021-03-04
20210060052
IN SITU METHODS OF INDUCING OF IMMUNE RESPONSE
2021-03-04
20210060053
DEVELOPMENT OF POLYLYSINE:EPIGALLOCATECHIN-3-O-GALLATE AND DSRNA POLYPLEXES FOR CONTROL OF MOSQUITOES
2021-03-04
20210060054
NOVEL PHARMACEUTICAL COMPOSITION COMPRISING PARTICLES AND METHODS OF MAKING SAME
2021-03-04
20210060055
METHODS AND COMPOSITIONS FOR TREATING CANCERS USING ANTISENSE
2021-03-04
20210060056
OPHTHALMIC COMPOSITIONS WITH IMPROVED DESSICATION PROTECTION AND RETENTION
2021-03-04
20210060057
NEW USE OF DEXTRAN SULFATE
2021-03-04
20210060058
COMPOSITIONS AND METHODS FOR TREATING HYDROGEN SULFIDE-MEDIATED HYPERDYNAMIC CIRCULATION
2021-03-04
20210060059
TREATMENT OF MYOPIC PROGRESSION
2021-03-04
20210060060
COMPOSITIONS AND METHODS FOR THE TREATMENT OF LUNG EMPHYSEMA AND OTHER FORMS OF COPD
2021-03-04
20210060061
SELENIUM-DOPED BLACK PHOSPHORUS PRODRUG AND PREPARATION METHOD THEREFOR
2021-03-04
20210060062
METHODS OF PRODUCING HUMAN RPE CELLS AND PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS
2021-03-04
20210060063
Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products
2021-03-04
20210060064
METHODS OF TREATING AGING-RELATED DISORDERS
2021-03-04
20210060065
Therapeutic Protein Compositions and Methods of Making and Using the Same
2021-03-04
20210060066
COMPOSITIONS AND METHODS FOR PLATELET ENRICHED FIBRIN CONSTRUCTS
2021-03-04
20210060067
ENHANCED IMMUNE CELLS USING DUAL SHRNA AND COMPOSITION INCLUDING THE SAME
2021-03-04
20210060068
BIOLOGICALLY RELEVANT ORTHOGONAL CYTOKINE/RECEPTOR PAIRS
2021-03-04
20210060069
COUPLED REDIRECTED CELLS AND USES THEREOF
2021-03-04
20210060070
ADOPTIVE CELL THERAPY AND METHODS OF DOSING THEREOF
2021-03-04
20210060071
Chimeric Antigen Receptor T Regulatory Cells for the Treatment of Atherosclerosis
2021-03-04
20210060072
METHODS AND COMPOSITIONS FOR TREATING CANCER
2021-03-04
20210060073
CANCER IMMUNOTHERAPY USING CD19-DIRECTED CHIMERIC ANTIGEN RECEPTORS
2021-03-04
20210060074
PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
2021-03-04
20210060075
METHODS FOR IDENTIFYING ANTIGEN-SPECIFIC T CELL RECEPTORS
2021-03-04
20210060076
T CELL RECEPTORS TARGETING PIK3CA MUTATIONS AND USES THEREOF
2021-03-04
20210060077
PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
2021-03-04
20210060078
PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
2021-03-04
20210060079
CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
2021-03-04
20210060080
CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
2021-03-04
20210060081
COMPOSITION FOR IMPROVING, PREVENTING OR TREATING SKIN DISEASE COMPRISING INDUCED PLURIPOTENCY STEM CELL-DERIVED MESENCHYMAL STEM CELLS PRETREATED WITH INTERFERON GAMMA AND EXOSOMES DERIVED THEREFROM
2021-03-04
20210060082
Ameliorating Nervous Systems Disorders
2021-03-04
20210060083
METHODS FOR GENERATING STEM CELL-DERIVED BETA CELLS AND USES THEREOF
2021-03-04
20210060084
AMNIOTIC FLUID FORMULATION FOR MODULATING IMMUNE RESPONSES
2021-03-04
20210060085
COMPOSITIONS AND METHODS FOR TREATING DIABETIC FOOT AND OTHER INJURIES AND SORES
2021-03-04
20210060086
COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER
2021-03-04
20210060087
TREATMENT AND PREVENTION OF PATHOGENIC BACTERIAL OVERGROWTH USING BUTYRATE-PRODUCING BACTERIA
2021-03-04
20210060088
COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT
2021-03-04
20210060089
METHODS FOR DETECTING RISK OF HAVING A BLOODSTREAM INFECTION AND COMPOSITIONS FOR REDUCING THE RISK
2021-03-04
20210060090
COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED THERETO
2021-03-04
20210060091
Bacteroides ovatus for Relieving Endotoxin Infection and Application thereof
2021-03-04
20210060092
PROBIOTIC AND PROBIOTIC COMBINATION FOR INHIBITION OF VANCOMYCIN-RESISTANT ENTEROCOCCI AND USE THEREOF
2021-03-04
20210060093
COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER
2021-03-04
20210060094
COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER
2021-03-04
20210060095
COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER
2021-03-04
20210060096
METHODS AND COMPOSITIONS USING BIFIDOBACTERIUM LONGUM TO MODULATE EMOTIONAL REACTIVITY AND TREAT OR PREVENT SUB-CLINICAL MOOD DISTURBANCES
2021-03-04